ITC delays decision on Samsung import ban

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

ITC delays decision on Samsung import ban

The ITC has asked for additional information about three Apple patents before deciding whether some Samsung products should be banned from the US for infringing them.

On Tuesday, the ITC extended the target date for completing the investigation until August 30 and requested additional arguments on three out of four patents that Judge Thomas Pender ruled that Samsung had infringed.

The Commission said it will reconsider Judge Pender’s decision, made in March. It also sought comments on how the public would be affected by an import ban on the Samsung products in question.

The products that Apple is asking the ITC to block from being imported into the US include Samsung’s Replenish, Intercept and Nexus 4G phones, and some versions of its Galaxy Tab computer.

The case, which dates back to July 2011, is one of numerous patent disputes between the two companies. It concerns patents covering certain semiconductor chips and modules and products utilising dram circuitry.

Apple alleges that Samsung infringed the design and other features of its iPhone, while Samsung claims Apple uses data-transmission technology owned by Samsung. The ITC is expected to make a final ruling in Samsung’s case against Apple on May 31.

more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article